Literature DB >> 19841192

CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements.

Berta N Vazquez1, Teresa Laguna, Juan Carabana, Michael S Krangel, Pilar Lauzurica.   

Abstract

CD69 is a type II C-type lectin involved in lymphocyte migration and cytokine secretion. CD69 expression represents one of the earliest available indicators of leukocyte activation and its rapid induction occurs through transcriptional activation. In this study we examined the molecular mechanism underlying mouse CD69 gene transcription in vivo in T and B cells. Analysis of the 45-kb region upstream of the CD69 gene revealed evolutionary conservation at the promoter and at four noncoding sequences (CNS) that were called CNS1, CNS2, CNS3, and CNS4. These regions were found to be hypersensitive sites in DNase I digestion experiments, and chromatin immunoprecipitation assays showed specific epigenetic modifications. CNS2 and CNS4 displayed constitutive and inducible enhancer activity in transient transfection assays in T cells. Using a transgenic approach to test CNS function, we found that the CD69 promoter conferred developmentally regulated expression during positive selection of thymocytes but could not support regulated expression in mature lymphocytes. Inclusion of CNS1 and CNS2 caused suppression of CD69 expression, whereas further addition of CNS3 and CNS4 supported developmental-stage and lineage-specific regulation in T cells but not in B cells. We concluded CNS1-4 are important cis-regulatory elements that interact both positively and negatively with the CD69 promoter and that differentially contribute to CD69 expression in T and B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841192      PMCID: PMC2787097          DOI: 10.4049/jimmunol.0900839

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Looping and interaction between hypersensitive sites in the active beta-globin locus.

Authors:  Bas Tolhuis; Robert Jan Palstra; Erik Splinter; Frank Grosveld; Wouter de Laat
Journal:  Mol Cell       Date:  2002-12       Impact factor: 17.970

2.  CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus.

Authors:  Xi He; Kyewon Park; Haitao Wang; Xiao He; Yi Zhang; Xiang Hua; Yi Li; Dietmar J Kappes
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

3.  A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.

Authors:  S Sawada; J D Scarborough; N Killeen; D R Littman
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

4.  An enhancer that directs lineage-specific expression of CD8 in positively selected thymocytes and mature T cells.

Authors:  W Ellmeier; M J Sunshine; K Losos; F Hatam; D R Littman
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

5.  The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex.

Authors:  S F Ziegler; S D Levin; L Johnson; N G Copeland; D J Gilbert; N A Jenkins; E Baker; G R Sutherland; A L Feldhaus; F Ramsdell
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

6.  Histone H3 lysine 4 methylation patterns in higher eukaryotic genes.

Authors:  Robert Schneider; Andrew J Bannister; Fiona A Myers; Alan W Thorne; Colyn Crane-Robinson; Tony Kouzarides
Journal:  Nat Cell Biol       Date:  2003-12-07       Impact factor: 28.824

7.  CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.

Authors:  Yanmei Han; Qiuli Guo; Minggang Zhang; Zhubo Chen; Xuetao Cao
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection.

Authors:  I Yamashita; T Nagata; T Tada; T Nakayama
Journal:  Int Immunol       Date:  1993-09       Impact factor: 4.823

9.  Comparative genomics of natural killer cell receptor gene clusters.

Authors:  James Kelley; Lutz Walter; John Trowsdale
Journal:  PLoS Genet       Date:  2005-08       Impact factor: 5.917

10.  Enhanced antitumor immunity in mice deficient in CD69.

Authors:  Enric Esplugues; David Sancho; Javier Vega-Ramos; Carlos Martínez; Uta Syrbe; Alf Hamann; Pablo Engel; Francisco Sánchez-Madrid; Pilar Lauzurica
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  23 in total

1.  Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1.

Authors:  Yan Li; Lina Lu; Shiguang Qian; John J Fung; Feng Lin
Journal:  J Immunol       Date:  2016-01-11       Impact factor: 5.422

2.  CD21(-/low) B cells in human blood are memory cells.

Authors:  K Thorarinsdottir; A Camponeschi; N Cavallini; O Grimsholm; L Jacobsson; I Gjertsson; I-L Mårtensson
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

Review 3.  Current concepts of follicle-stimulating hormone receptor gene regulation.

Authors:  Jitu W George; Elizabeth A Dille; Leslie L Heckert
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

4.  Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.

Authors:  Hongli Zhu; Wenyan Xu; Hong Liu; Huaquan Wang; Rong Fu; Yuhong Wu; Wen Qu; Guojin Wang; Jing Guan; Jia Song; Limin Xing; Zonghong Shao
Journal:  Int J Hematol       Date:  2016-03-11       Impact factor: 2.490

5.  Older age of rheumatoid arthritis onset is associated with higher activation status of peripheral blood CD4(+) T cells and disease activity.

Authors:  J Pawłowska; Z Smoleńska; A Daca; J M Witkowski; E Bryl
Journal:  Clin Exp Immunol       Date:  2010-12-13       Impact factor: 4.330

6.  Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines.

Authors:  Sergey V Kulemzin; Daria A Matvienko; Artur H Sabirov; Arpine M Sokratyan; Daria S Chernikova; Tatyana N Belovezhets; Anton N Chikaev; Aleksandr V Taranin; Andrey A Gorchakov
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

7.  Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.

Authors:  Peer W F Karmaus; Weimin Chen; Barbara L F Kaplan; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

8.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

9.  Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.

Authors:  Qian Qin; Zhaojun Yin; Xuanjun Wu; Karen M Haas; Xuefei Huang
Journal:  Biomaterials       Date:  2016-06-02       Impact factor: 12.479

10.  Basal LAT-diacylglycerol-RasGRP1 signals in T cells maintain TCRα gene expression.

Authors:  Evan Markegard; Evan Trager; Chih-wen Ou Yang; Weiguo Zhang; Arthur Weiss; Jeroen P Roose
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.